Based on Weighted Gene Co-Expression Network Analysis Reveals the Hub Immune Infiltration-Related Genes Associated with Ulcerative Colitis
Zongbiao Tan,Chuan Liu,Pengzhan He,Yanrui Wu,Jiao Li,Jixiang Zhang,Weiguo Dong
DOI: https://doi.org/10.2147/jir.s428503
IF: 4.5
2024-01-18
Journal of Inflammation Research
Abstract:Zongbiao Tan, &ast Chuan Liu, &ast Pengzhan He, &ast Yanrui Wu, Jiao Li, Jixiang Zhang, Weiguo Dong Department of Gastroenterology, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China &astThese authors contributed equally to this work Correspondence: Weiguo Dong, Department of Gastroenterology, Renmin Hospital of Wuhan University, No. 99 Zhangzhidong Road, Wuhan, Hubei Province, 430060, People's Republic of China, Tel +86 027-88041911, Email Purpose: Immune infiltration plays a pivotal role in the pathogenesis of mucosal damage in ulcerative colitis (UC). The objective of this study was to systematically analyze and identify genetic characteristics associated with immune infiltration in UC. Patients and Methods: Gene expression data from three independent datasets obtained from the Gene Expression Omnibus (GEO) were utilized. By employing the ssGSEA and CIBERSORT algorithms, we estimated the extent of immune cell infiltration in UC samples. Subsequently, Weighted Correlation Network Analysis (WGCNA) was performed to identify gene modules exhibiting significant associations with immune infiltration, and further identification of hub genes associated with immune infiltration was accomplished using least absolute shrinkage and selection operator (LASSO) regression analysis. The relationship between the identified hub genes and clinical information was subsequently investigated. Results: Our findings revealed significant activation of both innate and adaptive immune cells in UC. Notably, the expression levels of CD44, IL1B, LYN, and ITGA5 displayed strong correlations with immune cell infiltration within the mucosa of UC patients. Immunohistochemical analysis confirmed the significant upregulation of CD44, LYN, and ITGA5 in UC samples, and their expression levels were found to be significantly associated with common inflammatory markers, including the systemic immune inflammation indices, C-reactive protein, and erythrocyte sedimentation rate. Conclusion: CD44, LYN, and ITGA5 are involved in the immune infiltration pathogenesis of UC and may be potential therapeutic targets for UC. Keywords: Ulcerative colitis, Immune infiltration, WGCNA, CIBERSORT, LASSO Ulcerative colitis (UC) is one of the prominent forms of inflammatory bowel disease (IBD), which primarily affects the colorectal region, characterized by chronic abdominal pain, diarrhea, mucopurulent stools, and varying degrees of systemic manifestations. 1 Epidemiological studies indicate that UC has a higher prevalence in developed countries, such as Europe and the United States. 2 However, there has been a consistent increase in the incidence of UC in developing countries as a consequence of ongoing industrialization. 3 The recurrent and persistent nature of UC not only significantly impairs patients' quality of life but also imposes a substantial economic burden on society. 4 The etiology of UC remains incompletely understood, with current understanding suggesting a multifactorial interplay involving environmental factors, 5 genetic predisposition, 6 infectious agents, and immune dysregulation. 7 Among the various contributing factors, immune dysregulation plays a key role in the pathogenesis of UC, and the pathogenesis of UC involves complex interactions between the adaptive immune system and the innate immune system. CD4 + T cells play a central role in regulating adaptive immunity in UC. Compared with Crohn's disease (CD), UC is more characterized by pronounced infiltration of the colonic mucosa with Type 2 T helper (Th2) cell-associated cytokines, such as IL-5 and IL-13, suggesting the involvement of atypical type 2 immune responses. 8,9 At the same time, other immune cell types, including Type17 T helper (Th17) cells, T regulatory cells, and B lymphocytes, further increase the complexity of the immune response. Furthermore, the aberrant activation of the adaptive immune system triggers an exaggerated response from the innate immune system. This results in substantial infiltration of neutrophils and macrophages into the intestinal mucosa, leading to the release of proteinaceous particles and reactive oxygen species. These elements inflict cellular and tissue damage, ultimately leading to characteristic mucosal manifestations in UC, such as cryptitis, mucosal erosion, and ulcer formation. 7,9,10 Therefore, the central therapeutic strategy for managing UC primarily focuses on attenuating the inflammatory mechanisms. At present, therapeutic interventions for UC encompass non-specific modalities such as 5-aminosalicylic acid, glucocorticoids, and immunomodulators, alongside targeted therap -Abstract Truncated-
immunology